Technology

Will the UK learn from past efforts to champion innovation in the NHS? Leela Barham assesses the Phase 1 evaluation of its Innovation, Health and Wealth initiative.

Pfizer and Calibr in Heart Failure Research Collaboration

January 14th 2016

January 14, 2016.

Wave of Healthcare M&A to Continue in 2016, says Survey

January 13th 2016

January 13, 2016.

Parkinson's Disease Treatment Pipeline "Highly Active", Says Report

January 12th 2016

January 12, 2016.

FDA Violation Letters at All-Time Low in 2015

January 11th 2016

January 2011, 2016.

Shire to Buy Baxalta for $32 Billion

January 11th 2016

January 11, 2016.

Toward JP Morgan 2016: Pharm Exec's Top Tweets

ByCasey McDonald

January 8th 2016

January 08, 2016.

FDA: More “Me-Betters” and Focused Breakthroughs

ByJill Wechsler, Pharm Exec’s Washington Correspondent

January 7th 2016

January 05, 2016.

Priority Review Vouchers Raise Risks, say FDA Officials

ByJill Wechsler, Pharm Exec’s Washington Correspondent

January 6th 2016

January 06, 2016.

mAbs to Watch in 2016

ByRandi Hernandez

January 5th 2016

January 05, 2016.

Technology

Latest News

Roche Responds to Avastin Problem in India

European Pharma Recruitment Up in 2015

Tufts CSDD Report on New Patient Recruitment/Retention Approaches

Novartis Drug Set for Blockbuster Sales Following Latest FDA Approval

Merck, Pfizer and AZ Best at Digital Engagement with Physicians, Says Report

FDA’s CDER Previews 2016 Guidance Agenda

Industry Calls for Action on Drug-Resistant Infections

Florida's Nephron to Cut 250 Jobs

Former GSK Scientists Indicted for "Stealing Trade Secrets"

Shire Completes Acquisition of Dyax

Small Cell Lung Cancer Treatment Market "Will Escalate to $2.29 Billion by 2024"

Regen BioPharma and NIH in Cancer Research Collaboration

Italy's Money-Back Guarantee for Cancer Treatments

Hodgkin’s Lymphoma Treatment Market "Set to Quadruple to $1.4 Billion by 2024"

European Injectable Drug Delivery Market to Reach $207.3 Billion by 2020

UK NHS: Evaluating Innovation, Health and Wealth

Pfizer and Calibr in Heart Failure Research Collaboration

Wave of Healthcare M&A to Continue in 2016, says Survey

Parkinson's Disease Treatment Pipeline "Highly Active", Says Report

FDA Violation Letters at All-Time Low in 2015

Shire to Buy Baxalta for $32 Billion

Toward JP Morgan 2016: Pharm Exec's Top Tweets

FDA: More “Me-Betters” and Focused Breakthroughs

Priority Review Vouchers Raise Risks, say FDA Officials

mAbs to Watch in 2016

Trending on PharmExec

Brent Saunders: Eyeing New Horizons

TrumpRX Has a Blind Spot and It Can Redefine Patient Access

Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial

The GLP-1 Gold Rush

FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies